Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Platelets
|
April 17, 2026
Neural network reveals platelet age from fluorescence microscopy images
Johan A Slotman, Maurice Swinkels, Sophie Hordijk, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2024
Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV
Aarazo Barakzie, A J Gerard Jansen, Fabiano Cavalcante, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 30, 2022
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study
Tessa Noordermeer, Roger E G Schutgens, Chantal Visser, et al.
Haematologica
|
September 29, 2018
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
Maaike Rijkers, David Schmidt, Nina Lu, et al.
Stroke (Hoboken, N.J.)
|
January 23, 2026
Association of Fibrinolysis With Acute Ischemic Stroke Outcome in Patients Undergoing Thrombectomy: Modification by Additional Administration of tPA?
Aarazo Barakzie, Fabiano Cavalcante, Samantha J Donkel, et al.
Blood Advances
|
February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
David J Kuter, Jiri Mayer, Merlin Efraim, et al.
American Journal of Hematology
|
January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
Nichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Blood Advances
|
July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity
A J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
British Journal of Haematology
|
September 27, 2022
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
Maurice Swinkels, Ferdows Atiq, Petra E Bürgisser, et al.
Blood Advances
|
December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopenia
Chantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Platelets
|
April 17, 2026
Neural network reveals platelet age from fluorescence microscopy images
Johan A Slotman, Maurice Swinkels, Sophie Hordijk, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2024
Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV
Aarazo Barakzie, A J Gerard Jansen, Fabiano Cavalcante, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 30, 2022
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study
Tessa Noordermeer, Roger E G Schutgens, Chantal Visser, et al.
Haematologica
|
September 29, 2018
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
Maaike Rijkers, David Schmidt, Nina Lu, et al.
Stroke (Hoboken, N.J.)
|
January 23, 2026
Association of Fibrinolysis With Acute Ischemic Stroke Outcome in Patients Undergoing Thrombectomy: Modification by Additional Administration of tPA?
Aarazo Barakzie, Fabiano Cavalcante, Samantha J Donkel, et al.
Blood Advances
|
February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
David J Kuter, Jiri Mayer, Merlin Efraim, et al.
American Journal of Hematology
|
January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
Nichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Blood Advances
|
July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity
A J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
British Journal of Haematology
|
September 27, 2022
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
Maurice Swinkels, Ferdows Atiq, Petra E Bürgisser, et al.
Blood Advances
|
December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopenia
Chantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Page
of 6